INT MEDICAL Shareholder Transfers HK$293 Million Stake from Citibank to Merrill Lynch Far East

Stock News04-28

A recent filing with the Hong Kong Stock Exchange revealed that on April 27, a shareholder of INT MEDICAL transferred shares from Citibank to Merrill Lynch Far East. The transferred shares had a market value of HK$293 million, representing 5.43% of the company's issued share capital. This follows the company's announcement of its annual results for the fiscal year ending December 31, 2025. The company reported revenue of RMB 1.065 billion, a year-on-year increase of 25.06%. Gross profit was RMB 637 million, up 18.44% compared to the previous year. Net profit reached RMB 233 million, reflecting a growth of 22.43%. Earnings per share were RMB 1.26. The board proposed a final dividend of RMB 0.23 per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment